Zaltoprofen
Appearance
![]() | |
Clinical data | |
---|---|
Trade names | Soleton |
Other names | Zaxoprofen |
Drug class | NSAID |
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
ECHA InfoCard | 100.070.863 |
Chemical and physical data | |
Formula | C17H14O3S |
Molar mass | 298.36 g·mol−1 |
3D model (JSmol) | |
|
Zaltoprofen (JAN; trade name Soleton) is a nonsteroidal anti-inflammatory drug (NSAID) used as an analgesic, antipyretic, and anti-inflammatory agent.[1] It is a selective COX-2 inhibitor and also inhibits bradykinin-induced pain responses without blocking bradykinin receptors.[2]
It was approved for use in Japan in 1993.[3]
References
[edit]- ^ "Zaltoprofen". drugs.com.
- ^ Hirate K, Uchida A, Ogawa Y, Arai T, Yoda K (April 2006). "Zaltoprofen, a non-steroidal anti-inflammatory drug, inhibits bradykinin-induced pain responses without blocking bradykinin receptors". Neuroscience Research. 54 (4): 288–94. doi:10.1016/j.neures.2005.12.016. PMID 16473424. S2CID 27367042.
- ^ "Zaltoprofen Launched in Japan". thepharmaletter.com. September 20, 1993.